Feed Articles

2 stocks that could reach trillions of dollars by 2030

Achieving a market capitalisation of one trillion dollars is an incredibly challenging milestone that has so far been achieved by only a few global giants, especially in the technology sector, such as Apple, Amazon, Microsoft and Nvidia. But this exclusive group doesn't have to stay closed forever. Some companies have the potential to join it if they continue their growth.

In this article, we look at two companies that could reach trillions of dollars by 2030. Which companies are they?

Visa $V: The royal road to global growth

Visa, which operates one of the largest payment networks in the world, plays a key role in everyday transactions around the world. The company has benefited from a long-term trend away from cash and toward cashless payments, which has given it great results over the past decade. Currently, Visa is just under the $550 billion market capitalization mark, which means it would need to achieve a compound annual growth rate (CAGR) of around 10.5% to reach $1 trillion by 2030. Given Visa's growth history and its strong market position, this goal is achievable.

A key reason for Visa's success is network effects, which ensure that the more people use Visa cards, the more attractive its network is to merchants. This reciprocal relationship between users and merchants strengthens its dominant market position. Although credit cards are already widespread in many developed countries, Visa still sees huge growth potential in developing countries where the prevalence of these products is lower. The company estimates that it has the opportunity to capture up to $20 trillion worth of transactions.

With its strong market position and innovative approach, Visa has all the ingredients to sustain growth in excess of 10% per annum in the coming years, which could help it reach a trillion-dollar market capitalisation by the end of the decade.

Novo Nordisk $NVO: Healthcare pioneer and future giant

Novo Nordisk, a Danish pharmaceutical company specializing in diabetes and obesity treatments, is another company that may become a member of the "trillion dollar club." It currently has a market capitalization of around $400 billion, which means it would need to achieve a compound annual growth rate of around 16.5% to reach a trillion by 2030. While that may sound like a big challenge, Novo Nordisk has had impressive growth in recent years, particularly with its drugs Wegova and Ozempic, which have become global phenomena in the treatment of obesity and diabetes.

The market for weight loss drugs is growing rapidly and is estimated to be worth up to $150 billion by the early 2030s, a substantial increase from $24 billion in 2022. Although many other pharmaceutical companies are trying to tap into this lucrative market, Novo Nordisk still maintains a strong position with its extensive portfolio. Among its most promising innovations are the oral drug amycretin and the injectable CagriSema, which could generate annual revenues in excess of $20 billion by 2030.

In addition, Novo Nordisk is targeting other areas of high unmet need, including treatments for Alzheimer's disease and non-alcoholic steatohepatitis. With the development of new drugs for rare diseases and further innovations in diabetes and obesity, the company has a wide scope for growth. If it continues to win key approvals for its products, its sales and stock value should continue to rise, making it one of the leading candidates to reach the trillion-dollar mark by the end of this decade.

Disclaimer: There is plenty of inspiration to be found on Bulios, but stock selection and portfolio construction is up to you, so always conduct a thorough analysis of your own.

Source.

Stocks mentioned

A community member's personal view, not investment advice. Community Guidelines

Follow Bulios on Google News

Be among the first to discover new analyses, news and market moves.

Follow

Recommended articles

Read more

Expensive oil was supposed to sink them; these 3 cruise lines instead report records and expect further growth

Oil this year soared to $138 per barrel, and cruise ships, which burn hundreds of thousands of tons of it annually, were supposed to be the first to suffer. Instead, all three largest cruise operators raised their profit outlooks, yet for a dollar of profit the market pays almost twice as much for…

MC
Milan Charvat
· 6h
Read more
BLACK

Man with Parkinson's stood up and walked away after an injection. The drugmaker's stock still fell 20%

A man with Parkinson's who couldn't get up from a chair walked out through the door on his own after a year of treatment with his own cells. The company behind the treatment raised $140.6 million in its IPO, and three weeks later its stock is 20% cheaper, even though there hasn't been a single…

MC
Milan Charvat
· 10h
Read more
BLACK

Dividends Above 10%? No Problem for These Stocks

A yield of over 15% a year sounds almost unbelievable in the stock market, yet several established US-listed securities are offering just that today. Mortgage REITs and leveraged bond funds earn money from the difference between the yield on mortgages or bonds and the cost of short-term financing,…

KJ
Kryštof Jáně
· 13h

We use essential cookies to run the website and optional analytics cookies to measure usage.

Privacy policy